SCHEMBL5957572

SCHEMBL5957572

CC(C)CC1OC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14408036 0.97 BRD4 (0.33)
SCHEMBL20052459 0.87 BRD4 (0.32)
SCHEMBL16885241 0.72 BRD4 (0.40)
SCHEMBL24116508 0.72
SCHEMBL28541723 0.72 HTT (0.36)
SCHEMBL9015275 0.71 MAPT (0.43)
SCHEMBL14973709 0.70
SCHEMBL14553369 0.69 BRD4 (0.33)
SCHEMBL4495595 0.69 LMNA (0.33)
SCHEMBL1604494 0.69 RAB9A (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107636043-B Method for producing polyether carbonate polyols 科思创德国股份有限公司 2020-11-20 CN disclosed
US-20060063783-A1 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors ASTRAZENECA AB (GB) 2006-03-23 US disclosed
EP-1531821-A2 SULPHONYLPIPERIDINE DERIVATIVES CONTAINING AN ALKENYL OR ALKYNYL MOIETY FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS Astrazeneca AB (SE) 2005-05-25 EP disclosed
WO-2004006927-A2 SULPHONYLPIPERIDINE DERIVATIVES CONTAINING AN ALKENYL OR ALKYNLY MOIETY FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2004-01-22 WO disclosed